GVK Biosciences and Onconova Therapeutics Inc. Establish Novel Joint Development Partnership to Advance New Drugs for Cancer

Published: Jan 09, 2013

HYDERABAD, India & NEWTOWN, Pa.--(BUSINESS WIRE)--GVK BIO, Asia’s leading Contract Research and Development organization and Onconova Therapeutics, a U.S. based biopharmaceutical company primarily focused on discovery and development of novel small molecules for Oncology, today announced that they have entered into a novel joint partnership to develop new drugs for Cancer.

Back to news